An A to T transversion at position −5 of the Factor IX promoter results in hemophilia B

This publication has 9 references indexed in Scilit:

• A less severe form of Haemophilia B Leyden
  Nucleic Acids Research, 1990
• A past mutation at Isoleucine³⁹⁷ is now a common cause of moderate/mild haemophilia B
  British Journal of Haematology, 1990
• Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B
  Nature, 1990
• Haemophilia B: database of point mutations and short additions and deletions
  Nucleic Acids Research, 1990
• Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)
  Blood, 1989
• The putative factor IX gene promoter in hemophilia B Leyden
  Blood, 1988
• Comparison of phenotypic assessment and the use of two restriction fragment length polymorphisms in the diagnosis of the carrier state in haemophilia B
  British Journal of Haematology, 1986
• Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)
  Biochemistry, 1985
• Hemophilia B Leyden
  New England Journal of Medicine, 1982